Rilotumumab is a human monoclonal antibody designed for the treatment of solid tumors.

Fasinumab is a human monoclonal antibody designed for the treatment of pain.

Vesencumab is an immunomodulator designed for the treatment of solid malignancies.

Sodium oxybate is an orphan drug which was designed specifically for the treatment of narcolepsy.

It is designed for the treatment of ovarian cancer.

Dusigitumab is a human monoclonal antibody designed for the treatment of cancer.

Drozitumab is a human monoclonal antibody designed for the treatment of cancers.

Oxelumab is a human monoclonal antibody designed for the treatment of asthma.

The drug is designed for the treatment of patients undergoing percutaneous coronary interventions.

It is designed for the treatment of squamous cell carcinoma.